Your session is about to expire
← Back to Search
Radiation Therapy for Esophageal Cancer
Study Summary
This trial is testing if a combination of immunotherapy drugs, chemotherapy, and radiation therapy can shrink tumors more effectively than chemotherapy and radiation therapy alone in patients with esophageal and gastroesophageal junction adenocarcinoma who are undergoing surgery.
- Esophageal Cancer
- Esophageal Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can new patients join this research project?
"Yes, this trial is seeking participants and was last updated on November 12th, 2022. The listing was originally posted on January 17th, 2019."
Are there any other papers that mention Radiation Therapy?
"City of Hope Comprehensive Cancer Center first began studying Radiation Therapy in 1997. Since then, a total of 2020 clinical trials have completed with 1958 live studies. Many of these ongoing trials are based out of Carlisle, Pennsylvania."
At how many different hospitals is this experiment being conducted?
"At the moment, this trial is looking for participants from 100 different sites. The locations include Carlisle, Matthews and Appleton; in addition to other cities that are closer to you to minimize travel time if selected for the study."
For what sorts of medical conditions is Radiation Therapy commonly used?
"Radiation therapy is a cancer treatment that uses high-energy x-rays or particles to kill cancer cells. Radiation therapy can also be used to treat other conditions like unresectable melanoma, squamous cell carcinoma, and high risk of recurrence."
Share this study with friends
Copy Link
Messenger